Michael Howard Jones

Cell Guidance Systems Ltd. develops tools for stem cell treatments and medical research. Its products include microvesicles, cell culture media, PODS growth factors, matrigen softwell and SINEUP. The firm also offers karyotype analysis, custom medium production, NTA profiling service and PODS proteins services. The company was founded by Michael H. Jones in 2010 and is headquartered in Cambridge, the United Kingdom.

Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021.

Cigna Behavioral Health, Inc. provides healthcare services and plans. It manages behavioral health care benefits and employee assistance programs (EAPs) for health plan members nationwide. The firm's services include disability management programs for employees on short and long-term disability and referral services such as financial and legal services, childcare and eldercare. The company was founded in 1974 and is headquartered in Eden Prairie, MN.